Wall Street expects a year-over-year decline in earnings on higher revenues when Walgreens Boots Alliance (WBA) reports results for the quarter ended August 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on O ...

With yields of 8% or better at recent prices, these dividend payers are hard to ignore.If you're an investor looking for stocks that can produce giant streams of passive income, you may have noticed a couple of well-established dividend payers have been beaten down a long way over the past 12 months.The past year has been a lousy time for holding shares of Walgreens Boots Alliance (WBA 1.72%) and Western Union (WU -0.76%). Both of these dividend payers have been beaten down to near 52-week lows. At their be ...

Core Viewpoint - Walgreens Boots Alliance (WBA) is expected to report a significant decline in earnings for the fourth quarter of fiscal 2024, with a consensus estimate of 36 cents per share, reflecting a 46.3% decrease from the previous year, while revenues are projected to increase slightly by 1.1% to $35.8 billion [2][6]. Financial Performance - The earnings estimate for the fourth quarter has remained stable at 36 cents per share over the past 30 days, indicating a significant drop from the prior year's earnings [2]. - Walgreens has missed earnings estimates twice in the last four quarters, with an average surprise of 10.9% [3][4]. - The company has an Earnings ESP of +10.92%, but currently holds a Zacks Rank of 4 (Sell) [5]. Market Challenges - The company faces macroeconomic challenges, including labor shortages and supply chain disruptions, which have negatively impacted its performance [6]. - Ongoing inflation and reduced household savings have led to a difficult consumer environment, affecting retail sales, which are expected to decline by 0.6% in the upcoming quarter [6]. - Regulatory and reimbursement pressures in the pharmacy industry may have adversely affected pricing dynamics and profitability [7]. Segment Performance - The U.S. Healthcare segment is projected to see a revenue increase of 6.5% year-over-year, driven by Shields Health Solutions [8]. - The International division, particularly Boots U.K., is expected to show a 2% revenue improvement due to strong performance in both physical and digital channels [8]. Cost Management and Strategy - The company anticipates achieving $1 billion in cost savings through its Transformational Cost Management Program, with improvements in cash flow generation [9]. - Walgreens is undergoing a strategic review, planning to close nearly 25% of its underperforming U.S. Retail Pharmacy stores over the next three years [13]. - The company is also evaluating options for its majority stake in VillageMD, which may indicate a shift in strategy regarding value-based primary care [14]. Stock Performance - Walgreens shares have declined by 60.9% over the past year, significantly underperforming the industry and the S&P 500 [10]. - The stock is currently trading at a forward P/E ratio of 4.92X, lower than the industry average of 8.30X [12]. Future Outlook - The company is focusing on building an asset-light health services strategy and enhancing its digital offerings to better serve customers [15]. - Despite promising long-term initiatives, immediate operational challenges may hinder strong performance in the final quarter of fiscal 2024 [16].

Earnings and Market Sentiment - Walgreens Boots Alliance (WBA) is expected to report its Q4 FY24 earnings on October 15, 2024, pre-market [1] - The analyst anticipates potential disappointments in the upcoming earnings report, even if there is an upside surprise [1] Investment Strategy and Portfolio Management - The analyst manages a family portfolio primarily through a Self Managed Super Fund, focusing on alpha-generating investment ideas [1] - The investment approach is generalist, targeting any sector with perceived alpha potential compared to the S&P 500 [1] - Typical holding periods range from a few quarters to multiple years [1] Disclosure and Author Background - The analyst holds a beneficial long position in VOO through stock ownership, options, or other derivatives [2] - The article reflects the analyst's personal opinions and is not compensated by any company mentioned [2]

I noted on X late last year that Walgreens (NASDAQ: WBA ) was the standout, notoriously so, “Dow of the Dow.” That’s a moniker and category for components of the Dow Jones Industrial Average that sport the largest dividend yields. Market writersFreelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient way. My passion is p ...

The stock for this pharmacy chain has struggled mightily this year.With its stock trading at multiyear lows that have led to a nearly 12% dividend yield, Walgreens Boots Alliance (WBA 3.27%) has likely popped up on the radar of some value investors. As a result, some of them may be considering investing in the stock at these levels.Before making any decision on Walgreens, investors might want to look at five things regarding this company that could affect their choice.1. The stock is trading down 85% over t ...

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. Walgreens Boots Alliance presently has a stellar rank, in the top 10% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.Start slideshow: 10 Oversold Dividend ...

This eye-popping dividend yield may give you more headaches than passive income.It's tempting to gravitate toward dividend stocks that pay huge dividends. Take Walgreens Boots Alliance (WBA -0.35%) for example. The pharmacy chain's dividend yields over 11% at its current share price. In other words, investors get double-digit investment returns before factoring in any potential share price movement.However, there is never a free lunch in the stock market. It's rarely so easy.Peek behind the curtains and you ...

Last week, investors strongly contemplated that the easing of inflation, followed by the Fed’s long-awaited aggressive 50-bps rate cut on Sept.18, will provide a respite from the prolonged drab scenario within the retail pharmacy sector. While they were not wrong with respect to other industry players, Walgreens Boots’ (WBA) share price plunge, even amid the speculation of another half a percentage point cut in the rest of 2024, depicts a different story, denting investors’ enthusiasm.Since the rate cut, th ...

Walgreens stock has been a falling knife this year, but the company has levers it can pull on to strengthen its operations.Walgreens Boots Alliance (WBA -0.33%) is a highly risky stock to own right now. The pharmacy retailer has struggled with profitability, growing sales hasn't been easy, and its future is a big question mark at this point.This isn't going to be a suitable investment for most, given the risk involved. But if you're looking for a possible contrarian investment, below, I'll list the reasons ...